Bruno Osterwalder
106 works · 7,112 citations · h-index 27
Top works
- Comparison of Oral Capecitabine Versus Intravenous Fluorouracil Plus Leucovorin as First-Line Treatment in 605 Patients With Metastatic Colorectal Cancer: Results of a Randomized Phase III Study
- Multicenter Phase II Study of Capecitabine in Paclitaxel-Refractory Metastatic Breast Cancer
- Oral Capecitabine Compared With Intravenous Fluorouracil Plus Leucovorin in Patients With Metastatic Colorectal Cancer: Results of a Large Phase III Study
- First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous5-fluorouracil/leucovorin
- Phase I and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer.
- Capecitabine, an Oral Fluoropyrimidine Carbamate With Substantial Activity in Advanced Colorectal Cancer: Results of a Randomized Phase II Study
- Preliminary studies of a novel oral fluoropyrimidine carbamate: capecitabine.
- Multicenter, Phase II study of capecitabine in taxane-pretreated metastatic breast carcinoma patients
- Randomized, open-label, phase II trial of oral capecitabine (Xeloda®) vs. a reference arm of intravenous CMF (cyclophosphamide, methotrexate and 5-fluorouracil) as first-line therapy for advanced/metastatic breast cancer
- Treatment of severe aplastic anaemia with antilymphocyte globulin or bone-marrow transplantation.
- Delayed alloimmunization using random single donor platelet transfusions: a prospective study in thrombocytopenic patients with acute leukemia
- Treatment of severe aplastic anemia.
- Effect of food on the pharmacokinetics of capecitabine and its metabolites following oral administration in cancer patients.
- A Phase I study of capecitabine in combination with oral leucovorin in patients with intractable solid tumors.
- Capecitabine (Xeloda™) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients with advanced colorectal carcinoma
- Allogeneic marrow transplantation for chronic granulocytic leukemia
- Bone marrow transplantation for chronic myeloid leukemia.
- Randomised, phase II trial comparing oral capecitabine (Xeloda®) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclines
- A phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours
- Oral tramadol, a μ-opioid agonist and monoamine reuptake-blocker, and morphine for strong cancer-related pain